Exelixis
$19.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$19.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.10%) Today
+$0.04 (0.21%) As of 5:52 PM EDT after-hours
Why Robinhood?
You can buy or sell Exelixis and other stocks, options, ETFs, and crypto commission-free!
About EXEL
Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. Read More It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.
Employees
484
Headquarters
Parkway Alameda, California
Founded
1994
Market Cap
5.83B
Price-Earnings Ratio
9.39
Dividend Yield
0.00
Average Volume
2.36M
High Today
$19.54
Low Today
$18.88
Open Price
$19.23
Volume
2.75M
52 Week High
$25.31
52 Week Low
$13.42
Collections
Price Paid on Robinhood
7% Lower
Right Now
52 Week Low
$13.42
Average Price Paid
$20.74
52 Week High
$25.31
Analyst Ratings
69%
of 13 ratings
Buy
69%
Hold
31%
Sell
0%
EXEL Earnings
$0.12
$0.22
$0.31
$0.41
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 31, After Hours